Science Exchange Announces Outsourced R&D Partnership with Alector

partnership

  PALO ALTO, Calif.–Science Exchange, the world’s leading and most secure enterprise platform and aggregator for outsourced research and development (R&D), today announced a strategic partnership with Alector, a biotech company pioneering the discovery & development of immuno-neurology therapies for neurodegenerative disorders, to provide the company’s scientists access to a private R&D marketplace to accelerate […]

Read More…

Alzheimer’s Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS

alzheimers

New “CRO Finder” Connects Scientists with Specialized Resources by Cliff Culver, VP Strategy and GM, Science Exchange | blog.scienceexchange.com NEW YORK, June 7, 2017 — The Alzheimer’s Drug Discovery Foundation (ADDF), the only public charity solely focused on funding the development of drugs for Alzheimer’s, and Science Exchange today announced the launch of ADDF ACCESS, […]

Read More…